SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Suven Life Sciences to present pre-clinical data of their NCEs at SFN

14 Nov 2011 Evaluate

Suven Life Sciences will be presenting several data presentation from their portfolio of investigational neuroscience new chemical entities (NCEs) at SFN from 13th to 16th of November at Washington, DC, US. Neuroscience is the annual meeting of the Society for Neuroscience (SFN) and more than 30,000 Neuro scientists from all over the world covering all the major Pharma, biotech and research institutes will be participating.

Suven’s nine data presentation covers the early stage compounds from Histamine 3receptor antagonist, Nicotinic acetylcholine alpha- beta-2 receptor agonist and antagonist, Serotonin 5-HT4 receptor against in addition to 5HT6 antagonists to treat unmet medical needs of patients living with cognitive  dysfunction associated with Alzheimer’s, Schizophrenia, ADHD; Depression and Mood disorders and  Neuropathic pain.

These data presentation highlights company’s continued commitment to exploring new treatment  options addressing unmet medical need through novel mechanism and targets and address a market size of more than $30 billon.

Suven Life Sciences Share Price

220.75 -3.40 (-1.52%)
11-May-2026 09:37 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1842.30
Dr. Reddys Lab 1278.10
Cipla 1336.80
Zydus Lifesciences 932.30
Lupin 2273.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×